NCT00000176已完成3 期
Alzheimer's Disease Prevention Trial. A Multi-center, Randomized, Double-blind Placebo Controlled Trial of Estrogens to Prevent Alzheimer's Disease and Loss of Memory in Women.
National Institute on Aging (NIA)41 个研究点 分布在 1 个国家开始时间: 1999年11月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 试验地点
- 41
研究概览
简要总结
This is a three-year study to determine if estrogens can prevent memory loss and Alzheimer's disease in women with a family history of Alzheimer's disease.
详细描述
PREventing Postmenopausal memory loss and Alzheimer's with Replacement Estrogens (PREPARE) is a double-blind-placebo controlled trial to determine whether estrogen (or estrogen and progesterone) can delay the onset of memory loss or Alzheimer's Disease in elderly women with a family history of the disease.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 主要目的
- Prevention
- 盲法
- Double
入排标准
- 年龄范围
- 65 Years 至 —（Older Adult）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Healthy women 65 or older with a family history of memory problems not currently on estrogen.
排除标准
- •Significant neurological impairment
- •Current estrogen use
- •History of breast cancer
研究者
研究点 (41)
Loading locations...
相似试验
已完成
2 期
Alzheimer's Disease and Aging: Therapeutic Potential of EstrogenAlzheimer's DiseaseNCT00018343US Department of Veterans Affairs
已完成
2 期
Alzheimer's Disease: Therapeutic Potential of EstrogenAlzheimer DiseaseNCT00066157University of Wisconsin, Madison42
已完成
不适用
Estrogen Use in Protection From Cognitive DeclineAgingMenopauseNCT00097058Stanford University71
已完成
不适用
Prevention of Alzheimer's Disease by Vitamin E and Selenium (PREADVISE)Alzheimer DiseaseNCT00040378Frederick Schmitt4,246
尚未招募
1 期
Study on prevention mild to moderate Alzheimer's disease from exacerbating through invigorating spleen and kidneyAlzheimer's diseaseITMCTR2200006842onghua Hospital Shanghai University of Traditional Chinese Medicine